LENZ Therapeutics, Inc. (LENZ) Misses Q1 EPS by 53c
Tweet
Share
E-mailGet Alerts LENZ Hot Sheet
Join SI Premium – FREE
LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q1 EPS of ($0.53).
For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Old Dominion Freight Line (ODFL) Reiterated at Buy by Stifel Amid Seasonally Softer Q4/Q1
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- Concrete Pumping Holdings (BBCP) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
